All Type of News
New KFDA head nominated to Prof. Huh Keun.
As Dr. Park Jong-se the head of KFDA was arrested on Jan. 23 in charge of bribery, and his resign was accepted, Prof. Huh Keun, the former Dean of Yungnam Univ. College of Pharmacy succeeded his position.
Seoul dis...
Pharmacy community alerts to new retail pricing system.
The new open retail price labelling system launched from Jan. 20 has shown a good price stability in the market along with the popular drugs on the contrary to earlier fears for a price instability as resulted from th...
Handok initiated joint delivery projects with 4 drug companies.
Handok and 4 other pharmaceutical companies made an agreement for a joint warehouse utilization of drug delivery activity, which may show a significant sign for future drastic changes in drug distribution industry.
...
Hospital business stopped due to government drug price-cut policy.
The government overall price-cut policy of insurance drugs recently proceeded by the MOHW has caused the drug industry to withhold their drug supplies to hospitals in fear that a massive back order from hospitals may ...
Hot competition in commercialization of the first new drug in Korea.
Since the second half of 1980s the research oriented pharmaceutical companies have made quite an investment for an R&D of new drug discovery, and now is the time for these companies to visualize their fruit for the fi...
Patent application for gene recombinant drugs through electronic mail file possible.
The patent office announced the Ordinance No. 98-12 titled "The direction of listing and for the patent application including the nucleic acid base and aminoacid sequence" covering that the patent application includin...
KFDA intensifies quality of imported drugs before market release.
The KFDA finally established "The basic plan for drug quality control in 1999" and directed it to the regional offices for the purpose of reinforcing the post administrative control on the imported drugs and cosmetics...
MOHW announced revised bill of drug classification standard.
The current provision allows only the manufacturer to change the drug classification from the professional to the general or vice versa. However, in future the pharmaceutical or medical organization are qualified to...
Drug industry resists against overall 30% price slash
The drug industry strongly resists against the government intention of price slash overall by 30%, claiming it as "a deed of administrative violence without economic reasons".
The industry criticized the government...
Top ranks in drug industry changed in past 5 years.
The ranks in pharmaceutical manufacturers have been remarkably changed during the past 5 years. Up to the first half of 1990s the OTC oriented company occupied the top ranks but showed a gradual declining trend while ...
